For Immediate Release: September 29, 2011
Venous Disease Coalition Announces 2011 Research Award Winners at Its Annual Meeting
The Venous Disease Coalition (VDC) presented its annual research awards at the Vascular Disease Foundation’s eighth annual meeting in Washington. The awards recognize the important research relevant to the understanding and/or treatment of venous diseases.
The awards for studies published in 2010 in peer-reviewed medical literature are made in three distinct categories, including Basic Science, Clinical Outcomes and Quality Improvement and Implementation of Best Practices. The winning studies must provide important or novel insights for each category. The winners and their work are as follows:
The Basic Science Research Award was presented to Tobias Fuchs, Ph.D
Fuchs TA. Brill A. Duerschmied D. Schatzberg D. Monestier M. Myers DD Jr. Wrobleski SK. Wakefield TW. Hartwig JH. Wagner DD. Extracellular DNA traps promote thrombosis. (Proc Nat Acad Sci. 2010;107(36):15880-5.
The Clinical Outcomes Research Award was presented to Susan Kahn, MD
Kahn SR, Shrier I, Shapiro S, et al. Six-month exercise training program to treat post-thrombotic syndrome: a randomized controlled two-centre trial. (Canadian Medical Association Journal 2011;183:37)
The Research Related to Implementation of Quality Improvement, or Public Awareness of the Impact of Venous Disease Research Award was presented to James Douketis, MD
Douketis J, Tosetto A, Marcucci M, et al. Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. (British Medical Journal 2011;342:d813.)
and
Douketis J, Tosetto A, Marcucci M, et al. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism. (Annals of Internal Medicine. 2010;153(8):523-531.)
Winners received a plaque and $1,000 at the Vascular Disease Foundation’s annual meeting in Washington.
About the Venous Disease Coalition
The Venous Disease Coalition (VDC) (www.venousdiseasecoalition.org) promotes the urgent need to make venous thromboembolism or “VTE” a major U.S. public health priority. The VDC is an alliance of leading health professional societies and patient advocacy groups that have united around a common goal: to improve the survival rates and quality of life for individuals with, or at risk for, venous disease. It is an intiative of the Vascular Disease Foundation (www.vdf.org), a national, not-for-profit section 501(c)(3) organization and is supported in part by the following national sponsors: Eisai Inc., BSN Jobst, AngioDynamics, BioMedix, Cook Medical and Juzo.
###